This conference will benefit venture capitalists and angel investors who are interested in early-stage life sciences companies. Key attendees will be business development and senior executives from biotech, pharmaceutical and biomedical companies.
Be among the first to see a range of new companies spun off from Massachusetts research institutions, and see new technologies that are available for commercialization through licensing agreements and the creation of new companies.
MTTC has a few POSTER slots available. If you are interested in applying to present a poster please contact jgoldberg@umassp.edu.
Click here to download the Presenter Application Form.
May 1, 2006, 12:45-7:00 pm
The Conference Center at Harvard Medical School
77 Avenue Louis Pasteur, Boston , MA
Presenters and Exhibitors include BioBehavioral Diagnostics, Contego Pharmaceuticals, P.A. Technologies, and Perfusion Technology as well as emerging companies and new technologies from Massachusetts General Hospital , University of Massachusetts Lowell , Harvard Medical School , Northeastern University , University of Massachusetts Amherst , University of Massachusetts Medical School, and Beth Israel Deaconess Medical Center.
Keynote Speaker: Prof. Phillip Zamore Ph.D., UMass Medical School.
Keynote Speaker: Prof. Phillip Zamore Ph.D., UMass Medical School. Phil Zamore, a professor at UMass Medical School and a scientific co-founder of Alnylam will discuss the impact of RNAi both in the lab and in industry. RNAi technology, which Science Magazine called the Breakthrough of the Year in 2002, is a novel technology that can shut down the ability of a specific gene to express. The technology is being used extensively as a research tool to determine how genes work and has huge commercial applications as the basis of new therapeutics. Dr. Zamore was an author and a major contributor to a seminal work between MIT, UMass Medical School and the Max Plank Institute. He continues to be research leader in this field.
Formal company presentations: There will be formal presentations by a select group of early-stage spin-off companies and faculty seeking their first round of professional investment.
Reception and poster session: A networking reception will include poster presentations by all of the presenting companies and by additional institutions and incubating companies.
>> Back to top
|
12:45 - 1:15 |
Registration and Dessert Bar |
|
1:15 - 2:15 |
Welcome: Abi Barrow, Director of Massachusetts Technology Transfer Center , Conference Host Keynote: Prof. Phillip Zamore, UMass Medical School and co-founder of Alnylam. |
|
2:15 - 2:30 |
Mass Tech Portal Launch |
|
2:30 - 3:15 |
Company presentations - Session One Meiogen Biotechnology Corporation Harvard Medical School , Jose Halperin P.A. Technologies, LLC Encapsion |
|
3:15 - 3:30 |
Coffee Break |
|
3:30 - 5:00 |
Company presentations - Session Two SomRx, Inc IGAN Therapeutics, Inc. BioBehavioral Diagnostics Perfusion Technology LLC University of Massachusetts Medical School Contego Pharmaceuticals Northeastern University Enhanced Medical Systems |
|
5:00 - 7:00 |
Networking Reception and Poster Session |
|
|
|
>> Back to top
$3,000 Sponsorships Available
Sponsorship benefits:
For sponsorship information, please contact:
Abigail Barrow>> Back to top
Conference Sponsors |
 |
 |
 |
 |
